David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 47,755 shares at $1.78 ($83K) on 2018-08-31, disclosed to the SEC on 2018-09-05.
Scheduled sale ($83k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.78 | 715 | $1K | 1.5% |
| 2 | $1.78 | 1,551 | $3K | 3.3% |
| 3 | $1.78 | 21,589 | $38K | 46.4% |
| 4 | $1.69 | 717 | $1K | 1.5% |
| 5 | $1.69 | 1,553 | $3K | 3.2% |
| 6 | $1.69 | 21,630 |
| $37K |
| 44.1% |
| Total | $1.73 avg | 47,755 | $83K | 100% |
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |